Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
11.06
-0.59 (-5.06%)
At close: May 11, 2026, 4:00 PM EDT
11.04
-0.02 (-0.18%)
After-hours: May 11, 2026, 4:38 PM EDT
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $292.84 million as of May 11, 2026. Its market cap has increased by 14.23% in one year.
Market Cap
292.84M
Enterprise Value
267.71M
1-Year Change
14.23%
Ranking
Category
Stock Price
$11.06
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $292.84M, an increase of 404.85%. That is a compound annual growth rate of 46.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 309.02M | 59.79% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| C4 Therapeutics | 325.03M |
| Greenwich LifeSciences | 316.71M |
| LENZ Therapeutics | 315.43M |
| Zentalis Pharmaceuticals | 312.81M |
| Armata Pharmaceuticals | 304.57M |
| Editas Medicine | 304.49M |
| NervGen Pharma | 303.49M |
| Palisade Bio | 301.36M |